Following the publication on 24 September 2018 by the UK government of 24 technical notices on a no deal Brexit scenario, members of our IP team (Alice Boyd, Caroline Bass, Nicole Jadeja, Shalini Jayaweera, Claire Keepax and Rebecca Pakenham-Walsh) take each IP right in turn and explain the impact of a no Brexit deal on these IP rights.
Health Select Committee reports on the impact of Brexit on medicines, medical devices and substances of human origins
On Wednesday 21 March the House of Commons Health and Social Care Committee published a report titled "Brexit: medicines, medical devices and substances of human origins". The report emphasis that it is in the best interests of both citizens and the sector for there to be "the closest possible regulatory alignment" between the UK and EU post-Brexit. It also urges the Government to publish details of its contingency plans for the sector should a hard Brexit take place, to allow companies and health organisations to put in place the necessary plans.